The conference consists of four areas and one of the areas is Atlas Venture’s Investment Room. Atlas Venture Investment Room is already considered by many as one of the best biotech investment forums in Europe. At last year's event, 22 promising drug discovery and medtech companies presented to an audience of 45 high caliber investment firms and pharmaceutical companies

Below is a selection of presenting companies 2008:

Programme:

10.00 – PanGenetics, United Kingdom
10.15 – Evolva, Denmark
10.30 – Recopharma, Sweden
10.45 – Glide Pharma, United Kingdom
11.00 – Mobidiag, Finland
11.15 – Reneuron, United Kingdom
11.30 – Bionor Immuno, Norway
11.45 – Novacta Therapeutics, United Kingdom

12.00 – 13.00 Lunch

13.15 – Apitope, United Kingdom
13.30 – Balter Medical, Norway
13.45 – Vicore Pharma, Sweden
14.00 – INAGEN, Denmark
14.15 – Biosergen, Norway
14.30 – Karo Bio, Sweden
14.45 – FCMB, Denmark
15.00 – Affitech, Norway
15.15 – Colonix Medical, United Kingdom
15.30 – Equinox Pharma, United Kingdom
15.45 – Champagne Pitch - Phico Therapeutics, United Kingdom

If you have any queries regarding the investment room please contact Mattias Johansson:

Mattias Johansson
Ezenze Ltd
Email: mattias.johansson@ezenze.com
Office: +44 (0)20 7795 8132 
Fax: +44 (0)20 7795 4777

Examples of investors and biopharmaceuticals that attended 2007:

3i
Aescap
Alta Partners
Amgen
Apposite Capital LLP
BankInvest
Ferghana Partners
Firesteed Capital
FOCUS Clinical Drug Development GmbH
Gilde Investment Management
Global Life Sciences Ventures
Groupe LCF Rothschild
HBM Partners
HealthCap
Index Ventures
Industrifonden
Innovationskapital
Investor Growth Capital
Johnson & Johnson
Karolinska Innovation
KBC Peel Hunt
Kerentech
LCF Rothschild Venture Partners
London Seed Capital
Merck
MVM Life Science Partners
NGN Capital LLC
Novartis Venture Fund
Novo Venture
Omega Fund
Paramount Bio
Pfizer
Quintiles/NovaQuest
Sarsia Venture Management
Scottish Widows Inv. Partnership
Selvaag Venture Capital
Seraphim Capital
SGAM
SLS Ventures
TVM Capital
UCB Group
Vækstfonden
Wellcome Trust

Presenting companies 2007 - Atlas Venture’s Investment Room
ACE Biosciences
Advandx
Affitech
Avexxin
Biomonitor
Cyclacel
ENKAM Pharmaceuticals
Farallone Therapeutics
Ipsat Therapies
Hunter-Fleming
Lytix Biopharma
Medical Prognosis
Neuronova
Nuevolution
Optinose
Orla Protein Technologies
Oxford Genome Sciences
Oxford Biosensors
Pieris
Precisense
Silence Therapeutics
Zymetech